223463-02-3 Usage
General Description
2-Amino-4-cyanopyridine is a chemical compound with the molecular formula C6H5N3. It is a cyanopyridine derivative with a pyridine ring substituted with an amino group at the 2-position and a cyano group at the 4-position. It is commonly used as an intermediate in the production of pharmaceuticals, agrochemicals, and dyes. 2-Amino-4-cyanopyridine has been studied for its potential use in the treatment of various diseases and has shown promise in preclinical studies for treating cancer. It is important to handle this chemical with caution and use appropriate protective equipment and measures, as it may have harmful effects if not handled properly.
Check Digit Verification of cas no
The CAS Registry Mumber 223463-02-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,3,4,6 and 3 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 223463-02:
(8*2)+(7*2)+(6*3)+(5*4)+(4*6)+(3*3)+(2*0)+(1*2)=103
103 % 10 = 3
So 223463-02-3 is a valid CAS Registry Number.
223463-02-3Relevant articles and documents
TYK-2 INHIBITOR
-
Paragraph 0133-0135, (2022/01/05)
Disclosed herein is a compound of Formula (I) for inhibiting TYK2 and treating a disease associated with the undesirable tyk-2 activity (tyk-2 related diseases), a method of using the compounds disclosed herein for treating inflammatory or autoimmune disease, and a pharmaceutical composition comprising the same.
PYRIDYL OR PYRIMIDYL MTOR KINASE INHIBITORS
-
Page/Page column 65-66, (2020/12/30)
The invention relates to compounds or pharmaceutically acceptable salts thereof of formula (I): (I) wherein R1, R2, R3, R4, R4' and R5 are as defined in the description and claims; and comp
2 Tyrosine kinase mediated signal transduction inhibitors
-
Paragraph 0393; 0394; 0395, (2019/09/17)
Disclosed herein are compounds of Formula (), and pharmaceutically acceptable salts thereof, wherein R, R, R, R, R, X, X, X, X, X, and n are as defined herein, pharmaceutical compositions comprising same, and methods of preparation and use.
